In contrast, our study demonstrated that pharmacological inhibition of PDK1 significantly reduced lung tumor burden in an experimental metastasis model and suppressed tumor growth in orthotopic and heterotopic xenograft mouse models in vivo. Here, PDK1 is linked to neoplasm.